​

Privia Health Group (PRVA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PRVA Stock Forecast

Privia Health Group (PRVA) stock forecast, based on 19 Wall Street analysts, predicts a 12-month average price target of $30.00, with a high of $40.00 and a low of $25.00. This represents a 25.68% increase from the last price of $23.87.

$15 $20 $25 $30 $35 $40 High: $40 Avg: $30 Low: $25 Last Closed Price: $23.87

PRVA Stock Rating

Privia Health Group stock's rating consensus is Buy, based on 19 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 18 Buy (94.74%), 1 Hold (5.26%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 19 0 1 18 Strong Sell Sell Hold Buy Strong Buy

PRVA Price Target Upside V Benchmarks

TypeNameUpside
StockPrivia Health Group25.68%
SectorHealthcare Stocks 33.91%
IndustryHealthcare Information Services Stocks 34.92%

Price Target Trends

1M3M12M
# Anlaysts149
Avg Price Target$26.00$31.25$26.56
Last Closing Price$23.87$23.87$23.87
Upside/Downside8.92%30.92%11.27%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 255152--22
Mar, 256152--23
Feb, 256152--23
Jan, 256152--23
Dec, 245152--22
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 15, 2025Michael HaRobert W. Baird$26.00$24.107.88%8.92%
Feb 28, 2025JMP Securities$29.00$24.9716.14%21.49%
Feb 28, 2025Piper Sandler$40.00$24.9760.19%67.57%
Feb 28, 2025Canaccord Genuity$30.00$24.9720.14%25.68%
Jan 10, 2025Matthew SheaNeedham$25.00$20.5121.89%4.73%
Aug 26, 2024Michael HaRobert W. Baird$24.00$21.0314.12%0.54%
Aug 08, 2024Elizabeth AndersonEvercore ISI$22.00$19.3513.70%-7.83%
May 20, 2024Andrew MokBarclays$19.00$16.9012.43%-20.40%
May 15, 2024Jailendra SinghTruist Financial$24.00$18.0532.96%0.54%
Dec 08, 2022UBS$30.00$23.3128.70%25.68%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 10, 2025NeedhamBuyinitialise
Oct 10, 2024KeyBancOverweightinitialise
Aug 14, 2024RBC CapitalEqual-WeightEqual-Weighthold
Aug 08, 2024Evercore ISIOutperformOutperformhold
May 20, 2024BarclaysEqual-WeightEqual-Weighthold
Feb 03, 2023Goldman SachsBuyinitialise
Dec 08, 2022UBSBuyinitialise
Nov 11, 2022Canaccord GenuityBuyBuyhold
Aug 25, 2022Canaccord GenuityBuyBuyhold
Aug 12, 2022GuggenheimBuyBuyhold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.77$-0.11$0.20$0.12----
Avg Forecast$-1.81$-0.25$0.21$0.13$0.26$0.36$0.58$0.75
High Forecast$-1.72$-0.24$0.24$0.17$0.33$0.50$0.68$0.79
Low Forecast$-1.89$-0.27$0.19$0.10$0.17$0.26$0.48$0.68
Surprise %-2.21%-56.00%-4.76%-7.69%----

Revenue Forecast

$500M $1B $2B $2B $3B $4B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$966.22M$1.36B$1.66B$1.74B----
Avg Forecast$917.73M$1.33B$1.64B$1.70B$1.89B$2.13B$2.52B$2.96B
High Forecast$946.87M$1.38B$1.65B$1.71B$1.99B$2.13B$2.52B$3.11B
Low Forecast$880.42M$1.26B$1.53B$1.68B$1.69B$2.13B$2.52B$2.76B
Surprise %5.28%2.33%0.85%2.33%----

Net Income Forecast

$-250M $-180M $-110M $-40M $30M $100M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-190.65M$-12.06M$23.08M$14.38M----
Avg Forecast$-225.92M$-31.49M$26.33M$12.82M$33.58M$47.84M$82.25M$92.89M
High Forecast$-213.98M$-29.33M$29.40M$21.71M$41.14M$62.13M$84.79M$98.98M
Low Forecast$-235.25M$-33.16M$23.27M$11.94M$21.71M$32.31M$59.85M$84.43M
Surprise %-15.61%-61.69%-12.36%12.17%----

PRVA Forecast FAQ

Is Privia Health Group stock a buy?

Privia Health Group stock has a consensus rating of Buy, based on 19 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 18 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Privia Health Group is a favorable investment for most analysts.

What is Privia Health Group's price target?

Privia Health Group's price target, set by 19 Wall Street analysts, averages $30 over the next 12 months. The price target range spans from $25 at the low end to $40 at the high end, suggesting a potential 25.68% change from the previous closing price of $23.87.

How does Privia Health Group stock forecast compare to its benchmarks?

Privia Health Group's stock forecast shows a 25.68% upside, underperforming the average forecast for the healthcare stocks sector (33.91%) and underperforming the healthcare information services stocks industry (34.92%).

What is the breakdown of analyst ratings for Privia Health Group over the past three months?

  • April 2025: 22.73% Strong Buy, 68.18% Buy, 9.09% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 26.09% Strong Buy, 65.22% Buy, 8.70% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 26.09% Strong Buy, 65.22% Buy, 8.70% Hold, 0% Sell, 0% Strong Sell.

What is Privia Health Group’s EPS forecast?

Privia Health Group's average annual EPS forecast for its fiscal year ending in December 2025 is $0.26, marking a 116.67% increase from the reported $0.12 in 2024. Estimates for the following years are $0.36 in 2026, $0.58 in 2027, and $0.75 in 2028.

What is Privia Health Group’s revenue forecast?

Privia Health Group's average annual revenue forecast for its fiscal year ending in December 2025 is $1.89B, reflecting a 8.82% increase from the reported $1.74B in 2024. The forecast for 2026 is $2.13B, followed by $2.52B for 2027, and $2.96B for 2028.

What is Privia Health Group’s net income forecast?

Privia Health Group's net income forecast for the fiscal year ending in December 2025 stands at $33.58M, representing an 133.46% increase from the reported $14.38M in 2024. Projections indicate $47.84M in 2026, $82.25M in 2027, and $92.89M in 2028.